Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease

• Main Authors: Ohno Naohito (Author), Nagi-Miura Noriko (Author), Yamada Hitomi (Author), Yokouchi Yuki (Author), Nagao Tomokazu (Author), Oharaseki Toshiaki (Author), Takahashi Kei (Author), Saji Tsutomu (Author), Okazaki Tomio (Author), Suzuki Kazuo (Author)
• Format: Book
• Published: BMC, 2011-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Intravenous immunoglobulin (IVIg) treatment results in an effective response from patients with acute-phase Kawasaki disease (KD), but 16.5% of them remain nonresponsive to IVIg. To address this therapeutic challenge, we tried a new...